Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NRBF2 pseudogene 6 (NRBF2P6) is classified as a pseudogene and is not considered a protein-coding gene nor a direct drug target. Pseudogenes are DNA sequences that resemble known genes but typically do not encode functional proteins, though in some cases they may be transcribed into RNA. Some pseudogenes (in general) can regulate their parental gene at the RNA level through antisense interactions, miRNA decoy activity, or influencing RNA-binding protein interactions[2][4]. However, there is no evidence that NRBF2P6 specifically encodes a functional protein or acts as a therapeutic target. The functional NRBF2 gene, in contrast, encodes a protein involved in autophagy and has been reported to play roles in memory and neurobiology[1][3]. There is no available clinical or pharmacological data linking NRBF2P6 to any diseases, drug interactions, or therapeutic strategies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NRBF2 pseudogene 6 (NRBF2P6).